Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oesophageal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT00447226
What this trial is testing

Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists

Who this might be right for
Cancer
GlaxoSmithKline 32
Not applicableEnded earlyNCT03240679
What this trial is testing

Endoscopic Mucosal Resection and Cellular Matrix

Who this might be right for
Barretts Esophagus With High Grade DysplasiaBarrett Adenocarcinoma
Mayo Clinic 3
Early research (Phase 1)Study completedNCT00252889
What this trial is testing

Doxil Topotecan Doublet Cancer Study

Who this might be right for
Small Cell Lung CancerPancreatic CancerHead and Neck Cancer+2 more
Christiana Care Health Services 20
Not applicableWithdrawnNCT05001360
What this trial is testing

Study of FMT Combined With Nivolumab in Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaEsophagogastric Junction AdenocarcinomaEsophagus Adenocarcinoma
Fujian Cancer Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07701681
What this trial is testing

Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
ESCCGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Sun Yat-sen University 75
Testing effectiveness (Phase 2)Ended earlyNCT01365130
What this trial is testing

Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen

Who this might be right for
EsophagealGastrooesophageal CancerGastric Cancer
howard safran 15
Not applicableLooking for participantsNCT05965999
What this trial is testing

Lucid Registry Study

Who this might be right for
Barrett EsophagusEsophageal AdenocarcinomaBarretts Esophagus With Dysplasia+1 more
Lucid Diagnostics, Inc. 8,000
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Not applicableStudy completedNCT06381583
What this trial is testing

A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma

Who this might be right for
Esophagus CancerEsophageal Cancer StageEsophageal Cancer+18 more
City of Hope Medical Center 658
Testing effectiveness (Phase 2)Study completedNCT00675194
What this trial is testing

Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer

Who this might be right for
Gastric Cancer
Johannes Gutenberg University Mainz 120
Not applicableStudy completedNCT01269970
What this trial is testing

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Who this might be right for
Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)
Universitaire Ziekenhuizen KU Leuven
Not applicableUnknownNCT01957241
What this trial is testing

PLA for HCC and Esophageal ca Serum

Who this might be right for
Hepatocellular CarcinomaEsophageal Cancer
National Taiwan University Hospital 164
Testing effectiveness (Phase 2)Study completedNCT00544362
What this trial is testing

Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Federation Francophone de Cancerologie Digestive 33
Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Testing effectiveness (Phase 2)Ended earlyNCT00848783
What this trial is testing

Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers

Who this might be right for
Gastric CancerGastric AdenocarcinomaEsophageal Cancer
NYU Langone Health 8
Not applicableStudy completedNCT02606396
What this trial is testing

Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer

Who this might be right for
Esophageal Adenocarcinoma
Hunter Holmes Mcguire Veteran Affairs Medical Center 15
Early research (Phase 1)Looking for participantsNCT06623396
What this trial is testing

Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Who this might be right for
Mesothelin PositiveMesothelin-Expressing TumorsEsophageal Adenocarcinoma+5 more
Memorial Sloan Kettering Cancer Center 18
Not applicableLooking for participantsNCT05753748
What this trial is testing

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Who this might be right for
Barretts Esophagus With DysplasiaBarrett EsophagusEsophageal Adenocarcinoma
University of Colorado, Denver 680
Testing effectiveness (Phase 2)Ended earlyNCT00493025
What this trial is testing

Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Next Page